TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Over the Counter (OTC) Drugs & Dietary Supplements Market Report & Forecast 2022-2028

Global and United States Over the Counter (OTC) Drugs & Dietary Supplements Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 15 September 2022
  • Pages :124
  • Formats:
  • Report Code:SMR-7355724
OfferClick for best price

Best Price: $3480

Over the Counter OTC Drugs & Dietary Supplements Market Size, Share 2022


Market Analysis and Insights: Global Over the Counter OTC Drugs & Dietary Supplements Market

The global Over the Counter OTC Drugs & Dietary Supplements market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Over the Counter OTC Drugs & Dietary Supplements market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Over the Counter OTC Drugs & Dietary Supplements market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Over the Counter OTC Drugs & Dietary Supplements market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Over the Counter OTC Drugs & Dietary Supplements market.

Global Over the Counter OTC Drugs & Dietary Supplements Scope and Market Size

Over the Counter (OTC) Drugs & Dietary Supplements market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Over the Counter (OTC) Drugs & Dietary Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Over the Counter (OTC) Drugs & Dietary Supplements market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Analgesic & Pain Relievers

Dermatological Products

Cough, Cold, and Flu Products

Vitamin Supplements

Mineral Supplements

Ophthalmic Products

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacy

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Pfizer Inc.

Novartis International AG

Roche Holding AG

Merck & Co., Inc.

Sanofi S.A

Johnson & Johnson

Gilead Sciences

GlaxoSmithKline plc.

Bayer Healthcare AG

AstraZeneca plc.

Alacer Corp.

Alcon Inc.

Alfresa Pharma Corporation

Alkalon A/S

Alliance Healthcare

Allergan, Plc.

Reckitt Benckiser Plc.

Bausch & Lomb

AbbVie Inc.

The Colgate-Palmolive Company

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Over the Counter OTC Drugs & Dietary Supplements product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Over the Counter OTC Drugs & Dietary Supplements, with price, sales, revenue, and global market share of Over the Counter OTC Drugs & Dietary Supplements from 2019 to 2022.

Chapter 3, the Over the Counter OTC Drugs & Dietary Supplements competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Over the Counter OTC Drugs & Dietary Supplements breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Over the Counter OTC Drugs & Dietary Supplements market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Over the Counter OTC Drugs & Dietary Supplements.

Chapter 13, 14, and 15, to describe Over the Counter OTC Drugs & Dietary Supplements sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Over the Counter OTC Drugs & Dietary Supplements Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Over the Counter (OTC) Drugs & Dietary Supplements Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 124 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million) Introduction
1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Outlook 2017 VS 2022 VS 2028
1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size for the Year 2017-2028
1.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size for the Year 2017-2028
1.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Over the Counter (OTC) Drugs & Dietary Supplements in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Over the Counter (OTC) Drugs & Dietary Supplements Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
1.4.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
1.4.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
1.4.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
1.4.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Over the Counter (OTC) Drugs & Dietary Supplements by Type
2.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Segment by Type
2.1.1 Analgesic & Pain Relievers
2.1.2 Dermatological Products
2.1.3 Cough, Cold, and Flu Products
2.1.4 Vitamin Supplements
2.1.5 Mineral Supplements
2.1.6 Ophthalmic Products
2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017, 2022 & 2028)
2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2028)
2.4 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017, 2022 & 2028)
2.5 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2028)
3 Over the Counter (OTC) Drugs & Dietary Supplements by Application
3.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacy
3.1.4 Others
3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017, 2022 & 2028)
3.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2028)
3.4 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017, 2022 & 2028)
3.5 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2028)
4 Global Over the Counter (OTC) Drugs & Dietary Supplements Competitor Landscape by Company
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Company
4.1.1 Top Global Over the Counter (OTC) Drugs & Dietary Supplements Companies Ranked by Revenue (2021)
4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Player (2017-2022)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Concentration Ratio (CR)
4.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Over the Counter (OTC) Drugs & Dietary Supplements in 2021
4.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Headquarters, Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million) Type
4.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Headquarters and Area Served
4.3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Companies Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Company
4.5.1 Top Over the Counter (OTC) Drugs & Dietary Supplements Players in United States, Ranked by Revenue (2021)
4.5.2 United States Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2020, 2021 & 2022)
5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2017-2028)
5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2017-2022
5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2017-2028
6.1.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2017-2028
6.3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2017-2028
6.4.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Details
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.1.5 Pfizer Inc. Recent Development
7.2 Novartis International AG
7.2.1 Novartis International AG Company Details
7.2.2 Novartis International AG Business Overview
7.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.2.5 Novartis International AG Recent Development
7.3 Roche Holding AG
7.3.1 Roche Holding AG Company Details
7.3.2 Roche Holding AG Business Overview
7.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.3.5 Roche Holding AG Recent Development
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Company Details
7.4.2 Merck & Co., Inc. Business Overview
7.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.4.5 Merck & Co., Inc. Recent Development
7.5 Sanofi S.A
7.5.1 Sanofi S.A Company Details
7.5.2 Sanofi S.A Business Overview
7.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.5.5 Sanofi S.A Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Details
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.6.5 Johnson & Johnson Recent Development
7.7 Gilead Sciences
7.7.1 Gilead Sciences Company Details
7.7.2 Gilead Sciences Business Overview
7.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.7.5 Gilead Sciences Recent Development
7.8 GlaxoSmithKline plc.
7.8.1 GlaxoSmithKline plc. Company Details
7.8.2 GlaxoSmithKline plc. Business Overview
7.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.8.5 GlaxoSmithKline plc. Recent Development
7.9 Bayer Healthcare AG
7.9.1 Bayer Healthcare AG Company Details
7.9.2 Bayer Healthcare AG Business Overview
7.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.9.5 Bayer Healthcare AG Recent Development
7.10 AstraZeneca plc.
7.10.1 AstraZeneca plc. Company Details
7.10.2 AstraZeneca plc. Business Overview
7.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.10.5 AstraZeneca plc. Recent Development
7.11 Alacer Corp.
7.11.1 Alacer Corp. Company Details
7.11.2 Alacer Corp. Business Overview
7.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.11.5 Alacer Corp. Recent Development
7.12 Alcon Inc.
7.12.1 Alcon Inc. Company Details
7.12.2 Alcon Inc. Business Overview
7.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.12.5 Alcon Inc. Recent Development
7.13 Alfresa Pharma Corporation
7.13.1 Alfresa Pharma Corporation Company Details
7.13.2 Alfresa Pharma Corporation Business Overview
7.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.13.5 Alfresa Pharma Corporation Recent Development
7.14 Alkalon A/S
7.14.1 Alkalon A/S Company Details
7.14.2 Alkalon A/S Business Overview
7.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.14.5 Alkalon A/S Recent Development
7.15 Alliance Healthcare
7.15.1 Alliance Healthcare Company Details
7.15.2 Alliance Healthcare Business Overview
7.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.15.5 Alliance Healthcare Recent Development
7.16 Allergan, Plc.
7.16.1 Allergan, Plc. Company Details
7.16.2 Allergan, Plc. Business Overview
7.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.16.5 Allergan, Plc. Recent Development
7.17 Reckitt Benckiser Plc.
7.17.1 Reckitt Benckiser Plc. Company Details
7.17.2 Reckitt Benckiser Plc. Business Overview
7.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.17.5 Reckitt Benckiser Plc. Recent Development
7.18 Bausch & Lomb
7.18.1 Bausch & Lomb Company Details
7.18.2 Bausch & Lomb Business Overview
7.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.18.5 Bausch & Lomb Recent Development
7.19 AbbVie Inc.
7.19.1 AbbVie Inc. Company Details
7.19.2 AbbVie Inc. Business Overview
7.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.19.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.19.5 AbbVie Inc. Recent Development
7.20 The Colgate-Palmolive Company
7.20.1 The Colgate-Palmolive Company Company Details
7.20.2 The Colgate-Palmolive Company Business Overview
7.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction
7.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
7.20.5 The Colgate-Palmolive Company Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Over the Counter (OTC) Drugs & Dietary Supplements Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends
Table 3. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
Table 4. Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
Table 5. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
Table 6. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Over the Counter (OTC) Drugs & Dietary Supplements Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Player, 2017-2022
Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2021)
Table 15. Top Players of Over the Counter (OTC) Drugs & Dietary Supplements in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Over the Counter (OTC) Drugs & Dietary Supplements Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Over the Counter (OTC) Drugs & Dietary Supplements Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Pfizer Inc. Company Details
Table 31. Pfizer Inc. Business Overview
Table 32. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 33. Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 34. Pfizer Inc. Recent Development
Table 35. Novartis International AG Company Details
Table 36. Novartis International AG Business Overview
Table 37. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 38. Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 39. Novartis International AG Recent Development
Table 40. Roche Holding AG Company Details
Table 41. Roche Holding AG Business Overview
Table 42. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 43. Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 44. Roche Holding AG Recent Development
Table 45. Merck & Co., Inc. Company Details
Table 46. Merck & Co., Inc. Business Overview
Table 47. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 48. Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 49. Merck & Co., Inc. Recent Development
Table 50. Sanofi S.A Company Details
Table 51. Sanofi S.A Business Overview
Table 52. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 53. Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 54. Sanofi S.A Recent Development
Table 55. Johnson & Johnson Company Details
Table 56. Johnson & Johnson Business Overview
Table 57. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 58. Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 59. Johnson & Johnson Recent Development
Table 60. Gilead Sciences Company Details
Table 61. Gilead Sciences Business Overview
Table 62. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 63. Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 64. Gilead Sciences Recent Development
Table 65. GlaxoSmithKline plc. Company Details
Table 66. GlaxoSmithKline plc. Business Overview
Table 67. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 68. GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 69. GlaxoSmithKline plc. Recent Development
Table 70. Bayer Healthcare AG Company Details
Table 71. Bayer Healthcare AG Business Overview
Table 72. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 73. Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 74. Bayer Healthcare AG Recent Development
Table 75. AstraZeneca plc. Company Details
Table 76. AstraZeneca plc. Business Overview
Table 77. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 78. AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 79. AstraZeneca plc. Recent Development
Table 80. Alacer Corp. Company Details
Table 81. Alacer Corp. Business Overview
Table 82. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 83. Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 84. Alacer Corp. Recent Development
Table 85. Alcon Inc. Company Details
Table 86. Alcon Inc. Business Overview
Table 87. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 88. Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 89. Alcon Inc. Recent Development
Table 90. Alfresa Pharma Corporation Company Details
Table 91. Alfresa Pharma Corporation Business Overview
Table 92. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 93. Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 94. Alfresa Pharma Corporation Recent Development
Table 95. Alkalon A/S Company Details
Table 96. Alkalon A/S Business Overview
Table 97. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 98. Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 99. Alkalon A/S Recent Development
Table 100. Alliance Healthcare Company Details
Table 101. Alliance Healthcare Business Overview
Table 102. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 103. Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 104. Alliance Healthcare Recent Development
Table 105. Allergan, Plc. Company Details
Table 106. Allergan, Plc. Business Overview
Table 107. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 108. Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 109. Allergan, Plc. Recent Development
Table 110. Reckitt Benckiser Plc. Company Details
Table 111. Reckitt Benckiser Plc. Business Overview
Table 112. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 113. Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 114. Reckitt Benckiser Plc. Recent Development
Table 115. Bausch & Lomb Company Details
Table 116. Bausch & Lomb Business Overview
Table 117. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 118. Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 119. Bausch & Lomb Recent Development
Table 120. AbbVie Inc. Company Details
Table 121. AbbVie Inc. Business Overview
Table 122. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 123. AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 124. AbbVie Inc. Recent Development
Table 125. The Colgate-Palmolive Company Company Details
Table 126. The Colgate-Palmolive Company Business Overview
Table 127. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 128. The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
Table 129. The Colgate-Palmolive Company Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Over the Counter (OTC) Drugs & Dietary Supplements Product Picture
Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size 2017-2028 (US$ Million)
Figure 4. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size 2017-2028 (US$ Million)
Figure 6. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Share in Global 2017-2028
Figure 7. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered
Figure 8. Product Picture of Analgesic & Pain Relievers
Figure 9. Product Picture of Dermatological Products
Figure 10. Product Picture of Cough, Cold, and Flu Products
Figure 11. Product Picture of Vitamin Supplements
Figure 12. Product Picture of Mineral Supplements
Figure 13. Product Picture of Ophthalmic Products
Figure 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2022 & 2028
Figure 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2028) & (US$ Million)
Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)
Figure 17. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2022 & 2028
Figure 18. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2028) & (US$ Million)
Figure 19. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)
Figure 20. Product Picture of Hospital Pharmacies
Figure 21. Product Picture of Retail Pharmacies
Figure 22. Product Picture of Online Pharmacy
Figure 23. Product Picture of Others
Figure 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2022 & 2028
Figure 25. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2028) & (US$ Million)
Figure 26. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)
Figure 27. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2022 & 2028
Figure 28. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2028) & (US$ Million)
Figure 29. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)
Figure 30. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. U.S. Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate 2017-2028 (US$ Million)
Figure 34. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate 2017-2028 (US$ Million)
Figure 40. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Taiwan Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Indonesia Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Thailand Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Malaysia Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Philippines Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate 2017-2028 (US$ Million)
Figure 55. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. U.A.E Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 58. Pfizer Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 59. Novartis International AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 60. Roche Holding AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 61. Merck & Co., Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 62. Sanofi S.A Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 63. Johnson & Johnson Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 64. Gilead Sciences Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 65. GlaxoSmithKline plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 66. Bayer Healthcare AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 67. AstraZeneca plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 68. Alacer Corp. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 69. Alcon Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 70. Alfresa Pharma Corporation Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 71. Alkalon A/S Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 72. Alliance Healthcare Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 73. Allergan, Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 74. Reckitt Benckiser Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 75. Bausch & Lomb Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 76. AbbVie Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 77. The Colgate-Palmolive Company Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount